Specific antibody filter (SAF) binding capacity enhancement to remove anti-A antibodies

✍ Scribed by Shalini Gautam; Elena Y. Korchagina; Nicolai V. Bovin; William J. Federspiel

• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 340 KB
• Volume: 95B
• Category: Article
• ISSN: 1552-4973
• DOI: 10.1002/jbm.b.31707

✦ Synopsis

Abstract

Removal of Anti‐A/B antibodies prior to ABO‐incompatible transplantation can prevent hyperacute organ rejection. We are developing a specific antibody filter (SAF) device to selectively remove ABO blood group antibodies from the whole blood by utilizing immunoaffinity adsorption. The device consists of ultrafiltration hollow fiber membranes with synthetic antigens specific to bind blood group antibodies immobilized on the inner lumenal walls of the fibers. The aim of this study was to evaluate the effect of antigen molecular weight and surface activation process to increase the antibody binding capacity of the fiber membrane surface. A new higher molecular weight antigen Atri‐pNSA‐1000 compared with Atri‐pNPA‐30 (A‐trisaccharide (Atri) conjugated to activated polymers of Mol. wt. 1000 kDa and 30 kDa, respectively) was employed to improve accessibility of the antigen to bind antibodies. Also, a cyanogen bromide (CNBr) based surface activation method mediated by TEA in neutral pH medium was used to enhance the number of active sites for antigen binding compared to a strong basic medium of NaOH. Using a CNBr/TEA activation method and by immobilizing Atri‐pNSA‐1000 antigen, an antibody binding capacity (∼0.01 monoclonal anti‐A IgM nmol/cm^2^) was achieved on the fiber surface. This binding capacity was sufficient to reduce monoclonal antibody titer from 1:128 to final titer below 1:4 with a surface area to volume ratio that is similar to commercial dialysis device (∼1.1 m^2^ surface area for an average body blood volume of 5 L). © 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2010.